Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Baxter
Harvard Business School
AstraZeneca
Johnson and Johnson

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

Drug Price Trends for BUPRENORPHINE

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for BUPRENORPHINE

Average Pharmacy Cost for BUPRENORPHINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
BUPRENORPHINE 2 MG TABLET SL 42858-0501-03 0.62948 EACH 2019-09-18
BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET 65162-0415-03 1.60140 EACH 2019-09-18
BUPRENORPHINE 2 MG TABLET SL 00054-0176-13 0.62948 EACH 2019-09-18
BUPRENORPHINE 2 MG TABLET SL 50383-0924-93 0.62948 EACH 2019-09-18
BUPRENORPHINE 2 MG TABLET SL 62756-0459-83 0.62948 EACH 2019-09-18
BUPRENORPHINE 8 MG TABLET SL 00054-0177-13 0.95845 EACH 2019-09-18
BUPRENORPHINE 2 MG TABLET SL 00378-0923-93 0.62948 EACH 2019-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for BUPRENORPHINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
BUPRENORPHINE HCL 8MG/NALOXONE HCL 2MG TAB,SU AvKare, Inc. 65162-0416-03 30 100.00 3.33333 EACH 2018-10-30 - 2022-12-31 FSS
BUPRENORPHINE HCL 2MG/NALOXONE HCL 0.5MG TAB, AvKare, Inc. 50268-0144-15 50 126.80 2.53600 EACH 2018-01-01 - 2022-12-31 FSS
BBUPRENORPHINE HCL 8MG/NALOXONE HCL 2MG TAB,S AvKare, Inc. 50268-0145-15 50 163.58 3.27160 EACH 2018-01-01 - 2022-12-31 FSS
BUPRENORPHINE HCL 2MG/NALOXONE HCL 0.5MG TAB, AvKare, Inc. 42291-0174-30 30 49.62 1.65400 EACH 2018-01-01 - 2022-12-31 FSS
BUPRENORPHINE HCL 2MG TAB,SUBLINGUAL Golden State Medical Supply, Inc. 50383-0924-93 30 27.89 0.92967 EACH 2018-01-01 - 2022-12-31 FSS
BUPRENORPHINE HCL 8MG/NALOXONE HCL 2MG TAB,SU AvKare, Inc. 42291-0175-30 30 89.28 2.97600 EACH 2018-01-01 - 2022-12-31 FSS
BUPRENORPHINE 2MG/NALOXONE 0.5MG FILM,SUBLING Golden State Medical Supply, Inc. 43598-0579-30 30 69.37 2.31233 EACH 2019-07-18 - 2022-12-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Johnson and Johnson
Merck
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.